Thermo Fisher Scientific Inc.
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Marc N. Casper
- Full Time Employees
- 125,000
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 168 Third Avenue Waltham MA United States of America 02451
- IPO Date
- Mar 17, 1980
- CIK
- 0000097745
- Website
- thermofisher.com
- Similar Companies
- Business
- Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Company News
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for
Thermo Fisher acquires Sanofi's New Jersey manufacturing site
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing
Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine
Thermo Fisher Scientific Declares Quarterly Dividend
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?
Nalgene Outdoor Launches Wild Expressions Collaboration with AtomicChild to Inspire Mindfulness Just in Time for Summer Adventures and Back-to-School
Thermo Fisher Scientific: Recovery In Sight, Attractively Valued
4 Of The Hottest Great American SWANs For The 4th Of July
Thermo Fisher's NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 23, 2025
Thermo Fisher Scientific Rises 3.1% After Key Trading Signal
Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies
Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems
3Q Investing Outlook: Why Farmer Likes PEP, TMO, UNH
Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss, Femtonics, Hitachi, Thermo Fisher Scientific and More
Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions
Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business
Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition
Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms